Use of SGLT2i in noHCM With HFpEF

Clinical trial NCT06401343 · UNKNOWN

Trial details

NCT number: NCT06401343
Sponsor: China National Center for Cardiovascular Diseases
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertrophic Cardiomyopathy Heart Failure With Preserved Ejection Fraction

Start date: 2022-08-01
Primary completion: 2024-08-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.